Phillip Young

Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.

SentreHEART, Inc. develops catheter based solutions. Its products include products include LARIAT Suture Delivery Device, a solution for soft tissue closure; EndoCATH Occlusion Balloon, a technology for temporary occlusion and angiography; and FindrWIRZ Magnetic Guide Wire System, a solution for diagnostic and interventional procedures where control of placement and delivery is required. The company was founded by Russell Seiber, John Randall Liddicoat and William E. Cohn in 2005 and is headquartered in Redwood City, CA.

Aptus Endosystems, Inc. develops and manufactures medical equipment. It focuses on developing technologies to transform Endovascular Aneurysm Repair (EVAR), empowering physicians to perform minimally invasive aneurysm repair while still providing the control and potential long term durability of open surgical repair. The company was founded by Alan Kaganov and Lee Bolduc on August 7, 2002 and is headquartered in Sunnyvale, CA.

3Dfx Interactive, Inc. develops high performance, cost-effective graphic chips, graphic boards, software and related technology that enabled an interactive and realistic 3D experience across multiple hardware platforms. The company was founded on August 24, 1994 and is headquartered in San Jose, CA.

HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in 2007 and is headquartered in Redwood City, CA.

ApniCure, Inc. develops medical devices. It is a treatment option for adults with mild, moderate, and severe obstructive sleep apnea, designed without the inconvenience of a mask. The firm’s Winx system uses a proprietary platform technology called oral pressure therapy to treat obstructive sleep apnea. The company was founded by Jonathan Podmore, Jhon Edwards Crowe, Chris Daniel and Matthias Vaska in 2007 and is headquartered in Redwood City, CA.

SentreHEART, Inc. develops catheter based solutions. Its products include products include LARIAT Suture Delivery Device, a solution for soft tissue closure; EndoCATH Occlusion Balloon, a technology for temporary occlusion and angiography; and FindrWIRZ Magnetic Guide Wire System, a solution for diagnostic and interventional procedures where control of placement and delivery is required. The company was founded by Russell Seiber, John Randall Liddicoat and William E. Cohn in 2005 and is headquartered in Redwood City, CA.

Aptus Endosystems, Inc. develops and manufactures medical equipment. It focuses on developing technologies to transform Endovascular Aneurysm Repair (EVAR), empowering physicians to perform minimally invasive aneurysm repair while still providing the control and potential long term durability of open surgical repair. The company was founded by Alan Kaganov and Lee Bolduc on August 7, 2002 and is headquartered in Sunnyvale, CA.

Aptus Endosystems, Inc. develops and manufactures medical equipment. It focuses on developing technologies to transform Endovascular Aneurysm Repair (EVAR), empowering physicians to perform minimally invasive aneurysm repair while still providing the control and potential long term durability of open surgical repair. The company was founded by Alan Kaganov and Lee Bolduc on August 7, 2002 and is headquartered in Sunnyvale, CA.

3Dfx Interactive, Inc. develops high performance, cost-effective graphic chips, graphic boards, software and related technology that enabled an interactive and realistic 3D experience across multiple hardware platforms. The company was founded on August 24, 1994 and is headquartered in San Jose, CA.

Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.

USVP Management Co. LLC (US Venture Partners) is a venture capital firm founded in 1981 by Bill Bowes. The firm is headquartered in Menlo Park, California.

Signal Pharmaceuticals Inc is pioneering the discovery and development of small molecule therapeutics which regulate the transcription factors involved in the progression of a number of inflammatory, viral and neurological diseases. The core technology for the company's research was discovered in the laboratories of three of its founders, and has been licensed from the University of California and the Salk Institute. (SB) It was located in San Diego, CA.

Part of Johnson & Johnson, FemRx, Inc. is a company that produces medical products for gynecological disorders. The company is based in Sunnyvale, CA. FemRx was acquired by Johnson & Johnson on November 06, 1998 for $20.99 million.

Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.

Aerogen, Inc. develops and manufactures aerosol products for treatment of respiratory disorders in the critical care setting. Its products include Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-C controller, and USB controller. The company is headquartered in Deerfield, IL.

Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.

Aerogen, Inc. develops and manufactures aerosol products for treatment of respiratory disorders in the critical care setting. Its products include Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-C controller, and USB controller. The company is headquartered in Deerfield, IL.

Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.

Penederm Incorporated, Foster City, California, develops and commercializes dermatological products and unique topical delivery technologies that enhance delivery of drugs and skin care products.

Penederm Incorporated, Foster City, California, develops and commercializes dermatological products and unique topical delivery technologies that enhance delivery of drugs and skin care products.

3Dfx Interactive, Inc. develops high performance, cost-effective graphic chips, graphic boards, software and related technology that enabled an interactive and realistic 3D experience across multiple hardware platforms. The company was founded on August 24, 1994 and is headquartered in San Jose, CA.

SentreHEART, Inc. develops catheter based solutions. Its products include products include LARIAT Suture Delivery Device, a solution for soft tissue closure; EndoCATH Occlusion Balloon, a technology for temporary occlusion and angiography; and FindrWIRZ Magnetic Guide Wire System, a solution for diagnostic and interventional procedures where control of placement and delivery is required. The company was founded by Russell Seiber, John Randall Liddicoat and William E. Cohn in 2005 and is headquartered in Redwood City, CA.

Aptus Endosystems, Inc. develops and manufactures medical equipment. It focuses on developing technologies to transform Endovascular Aneurysm Repair (EVAR), empowering physicians to perform minimally invasive aneurysm repair while still providing the control and potential long term durability of open surgical repair. The company was founded by Alan Kaganov and Lee Bolduc on August 7, 2002 and is headquartered in Sunnyvale, CA.

Aerogen, Inc. develops and manufactures aerosol products for treatment of respiratory disorders in the critical care setting. Its products include Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-C controller, and USB controller. The company is headquartered in Deerfield, IL.

Aptus Endosystems, Inc. develops and manufactures medical equipment. It focuses on developing technologies to transform Endovascular Aneurysm Repair (EVAR), empowering physicians to perform minimally invasive aneurysm repair while still providing the control and potential long term durability of open surgical repair. The company was founded by Alan Kaganov and Lee Bolduc on August 7, 2002 and is headquartered in Sunnyvale, CA.

ApniCure, Inc. develops medical devices. It is a treatment option for adults with mild, moderate, and severe obstructive sleep apnea, designed without the inconvenience of a mask. The firm’s Winx system uses a proprietary platform technology called oral pressure therapy to treat obstructive sleep apnea. The company was founded by Jonathan Podmore, Jhon Edwards Crowe, Chris Daniel and Matthias Vaska in 2007 and is headquartered in Redwood City, CA.

Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.

Aerogen, Inc. develops and manufactures aerosol products for treatment of respiratory disorders in the critical care setting. Its products include Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-C controller, and USB controller. The company is headquartered in Deerfield, IL.

Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.

Aptus Endosystems, Inc. develops and manufactures medical equipment. It focuses on developing technologies to transform Endovascular Aneurysm Repair (EVAR), empowering physicians to perform minimally invasive aneurysm repair while still providing the control and potential long term durability of open surgical repair. The company was founded by Alan Kaganov and Lee Bolduc on August 7, 2002 and is headquartered in Sunnyvale, CA.

Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.

RelayHealth Corp. provides online healthcare communication services. Its network is designed to streamline clinical, financial and administrative communication between patients, providers, payers, pharmacies, pharmaceutical manufacturers, and financial institutions. The firm works to accelerate the delivery of care and improve financial performance through solutions such as online consultation of physicians by patients, electronic prescribing, point-of-service pharmacy claims resolution by payers, pre-visit patient financial clearance by providers, and post-visit provider bill settlement by payers and patients. The company was founded by Assaf Morag, Niall Murphy, Ofir Baharav, Giovanni M. Colella, and Gary Gannot and is headquartered in Alpharetta, GA.

Aerogen, Inc. develops and manufactures aerosol products for treatment of respiratory disorders in the critical care setting. Its products include Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-C controller, and USB controller. The company is headquartered in Deerfield, IL.

Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.

Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.

Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.

RelayHealth Corp. provides online healthcare communication services. Its network is designed to streamline clinical, financial and administrative communication between patients, providers, payers, pharmacies, pharmaceutical manufacturers, and financial institutions. The firm works to accelerate the delivery of care and improve financial performance through solutions such as online consultation of physicians by patients, electronic prescribing, point-of-service pharmacy claims resolution by payers, pre-visit patient financial clearance by providers, and post-visit provider bill settlement by payers and patients. The company was founded by Assaf Morag, Niall Murphy, Ofir Baharav, Giovanni M. Colella, and Gary Gannot and is headquartered in Alpharetta, GA.

RelayHealth Corp. provides online healthcare communication services. Its network is designed to streamline clinical, financial and administrative communication between patients, providers, payers, pharmacies, pharmaceutical manufacturers, and financial institutions. The firm works to accelerate the delivery of care and improve financial performance through solutions such as online consultation of physicians by patients, electronic prescribing, point-of-service pharmacy claims resolution by payers, pre-visit patient financial clearance by providers, and post-visit provider bill settlement by payers and patients. The company was founded by Assaf Morag, Niall Murphy, Ofir Baharav, Giovanni M. Colella, and Gary Gannot and is headquartered in Alpharetta, GA.

RelayHealth Corp. provides online healthcare communication services. Its network is designed to streamline clinical, financial and administrative communication between patients, providers, payers, pharmacies, pharmaceutical manufacturers, and financial institutions. The firm works to accelerate the delivery of care and improve financial performance through solutions such as online consultation of physicians by patients, electronic prescribing, point-of-service pharmacy claims resolution by payers, pre-visit patient financial clearance by providers, and post-visit provider bill settlement by payers and patients. The company was founded by Assaf Morag, Niall Murphy, Ofir Baharav, Giovanni M. Colella, and Gary Gannot and is headquartered in Alpharetta, GA.

Aerogen, Inc. develops and manufactures aerosol products for treatment of respiratory disorders in the critical care setting. Its products include Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-C controller, and USB controller. The company is headquartered in Deerfield, IL.

HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in 2007 and is headquartered in Redwood City, CA.

RelayHealth Corp. provides online healthcare communication services. Its network is designed to streamline clinical, financial and administrative communication between patients, providers, payers, pharmacies, pharmaceutical manufacturers, and financial institutions. The firm works to accelerate the delivery of care and improve financial performance through solutions such as online consultation of physicians by patients, electronic prescribing, point-of-service pharmacy claims resolution by payers, pre-visit patient financial clearance by providers, and post-visit provider bill settlement by payers and patients. The company was founded by Assaf Morag, Niall Murphy, Ofir Baharav, Giovanni M. Colella, and Gary Gannot and is headquartered in Alpharetta, GA.

HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in 2007 and is headquartered in Redwood City, CA.

Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.

SentreHEART, Inc. develops catheter based solutions. Its products include products include LARIAT Suture Delivery Device, a solution for soft tissue closure; EndoCATH Occlusion Balloon, a technology for temporary occlusion and angiography; and FindrWIRZ Magnetic Guide Wire System, a solution for diagnostic and interventional procedures where control of placement and delivery is required. The company was founded by Russell Seiber, John Randall Liddicoat and William E. Cohn in 2005 and is headquartered in Redwood City, CA.

Penederm Incorporated, Foster City, California, develops and commercializes dermatological products and unique topical delivery technologies that enhance delivery of drugs and skin care products.

Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.

Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.

HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in 2007 and is headquartered in Redwood City, CA.

Aerogen, Inc. develops and manufactures aerosol products for treatment of respiratory disorders in the critical care setting. Its products include Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-C controller, and USB controller. The company is headquartered in Deerfield, IL.

3Dfx Interactive, Inc. develops high performance, cost-effective graphic chips, graphic boards, software and related technology that enabled an interactive and realistic 3D experience across multiple hardware platforms. The company was founded on August 24, 1994 and is headquartered in San Jose, CA.

Aptus Endosystems, Inc. develops and manufactures medical equipment. It focuses on developing technologies to transform Endovascular Aneurysm Repair (EVAR), empowering physicians to perform minimally invasive aneurysm repair while still providing the control and potential long term durability of open surgical repair. The company was founded by Alan Kaganov and Lee Bolduc on August 7, 2002 and is headquartered in Sunnyvale, CA.

3Dfx Interactive, Inc. develops high performance, cost-effective graphic chips, graphic boards, software and related technology that enabled an interactive and realistic 3D experience across multiple hardware platforms. The company was founded on August 24, 1994 and is headquartered in San Jose, CA.

RelayHealth Corp. provides online healthcare communication services. Its network is designed to streamline clinical, financial and administrative communication between patients, providers, payers, pharmacies, pharmaceutical manufacturers, and financial institutions. The firm works to accelerate the delivery of care and improve financial performance through solutions such as online consultation of physicians by patients, electronic prescribing, point-of-service pharmacy claims resolution by payers, pre-visit patient financial clearance by providers, and post-visit provider bill settlement by payers and patients. The company was founded by Assaf Morag, Niall Murphy, Ofir Baharav, Giovanni M. Colella, and Gary Gannot and is headquartered in Alpharetta, GA.

Aerogen, Inc. develops and manufactures aerosol products for treatment of respiratory disorders in the critical care setting. Its products include Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-C controller, and USB controller. The company is headquartered in Deerfield, IL.

3Dfx Interactive, Inc. develops high performance, cost-effective graphic chips, graphic boards, software and related technology that enabled an interactive and realistic 3D experience across multiple hardware platforms. The company was founded on August 24, 1994 and is headquartered in San Jose, CA.

Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.

Penederm Incorporated, Foster City, California, develops and commercializes dermatological products and unique topical delivery technologies that enhance delivery of drugs and skin care products.

Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.

Penederm Incorporated, Foster City, California, develops and commercializes dermatological products and unique topical delivery technologies that enhance delivery of drugs and skin care products.

Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.